Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Next earnings report
No upcoming earnings date is currently scheduled for ELOXX PHARMACEUTICALS INCORPORATED in our data window. Dates typically appear about a quarter ahead. Check back soon, or browse the full earnings calendar.
Report dates are estimates and companies can reschedule. Estimates are analyst consensus, not guidance. Price moves are close-to-close changes around each report date. For informational purposes only, not investment advice.
| Quarter | EPS | Price move | |||||
|---|---|---|---|---|---|---|---|
| Est. | Adj. | Result | GAAP | 1D Pre | On-Day | 1D Post | |
| Q ended Mar 31, 2026Reported Aug 10, 2026 | — | — | — | $-0.08 | 1D Pre | On-Day | 1D Post |
| Q ended Sep 30, 2023Reported Nov 12, 2023 · after close | $-21.67 | $-14.41 | Beat +33.5% | — | 1D Pre | On-Day | 1D Post |
| Q ended Jun 30, 2023Reported Aug 14, 2023 · after close | $-16.94 | $-21.56 | Miss -27.3% | — | 1D Pre | On-Day | 1D Post |
| Q ended Mar 31, 2023Reported Apr 3, 2023 · after close | $-28.05 | $-31.68 | Miss -12.9% | — | 1D Pre | On-Day | 1D Post |
| Quarter | EPS | Price move | |||||
|---|---|---|---|---|---|---|---|
| Est. | Adj. | Result | GAAP | 1D Pre | On-Day | 1D Post | |
| Q ended Mar 31, 2026Reported Aug 10, 2026 | — | — | — | $-0.08 | 1D Pre-0.8% | On-Day-3.2% | 1D Post— |
| Q ended Sep 30, 2023Reported Nov 12, 2023 · after close | $-21.67 | $-14.41 | Beat +33.5% | — | 1D Pre— | On-Day— | 1D Post-0.1% |
| Q ended Jun 30, 2023Reported Aug 14, 2023 · after close | $-16.94 | $-21.56 | Miss -27.3% | — | 1D Pre— | On-Day— | 1D Post-0.1% |
| Q ended Mar 31, 2023Reported Apr 3, 2023 · after close | $-28.05 | $-31.68 | Miss -12.9% | — | 1D Pre— | On-Day— | 1D Post-0.1% |